Actively Recruiting

Phase Not Applicable
Age: 30Years - 69Years
FEMALE
Healthy Volunteers
NCT06528184

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

Led by National Healthcare Group Polyclinics · Updated on 2025-02-10

650

Participants Needed

1

Research Sites

121 weeks

Total Duration

On this page

Sponsors

N

National Healthcare Group Polyclinics

Lead Sponsor

N

National Healthcare Group, Singapore

Collaborating Sponsor

AI-Summary

What this Trial Is About

Primary objective of the study is to determine the extent that offering of self-sampling in addition to clinician-sampling Human Papillomavirus (HPV) DNA testing will increase detection of HPV DNA through an increase in uptake rates of cervical cancer screening as compared to offering clinician-sampling HPV DNA testing alone. The hypothesis is that offering additional self-sampling will increase the detection of high-risk HPV DNA by at least 7.7%.

CONDITIONS

Official Title

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

Who Can Participate

Age: 30Years - 69Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female Singapore citizens aged 30 to 69 years
  • Due for cervical cancer screening
  • Have engaged in sexual intercourse before
  • Able to give informed consent
  • Able to read and communicate in English, Chinese, or Malay
Not Eligible

You will not qualify if you...

  • Virgin (virgo intacta)
  • Currently pregnant
  • History of cervical cancer, precancerous cervical lesions, or total hysterectomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Healthcare Group Polyclinics

Singapore, Singapore, Singapore, 138543

Actively Recruiting

Loading map...

Research Team

N

Ng Xin Rong, MBBS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings | DecenTrialz